These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35938131)

  • 1. Prognostic Nutritional Index Predicts Response and Prognosis in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Ni L; Huang J; Ding J; Kou J; Shao T; Li J; Gao L; Zheng W; Wu Z
    Front Nutr; 2022; 9():823087. PubMed ID: 35938131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta‑analysis.
    Kou J; Huang J; Li J; Wu Z; Ni L
    Clin Exp Med; 2023 Nov; 23(7):3895-3905. PubMed ID: 36966477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Hou S; Song D; Hao R; Li L; Zhang Y; Zhu J
    Front Immunol; 2024; 15():1382417. PubMed ID: 38966640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of prognostic nutritional index in advanced cancer receiving PD-1/L1 inhibitors: A meta-analysis.
    Li P; Lai Y; Tian L; Zhou Q
    Cancer Med; 2022 Aug; 11(16):3048-3056. PubMed ID: 35297197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Impact of Prognostic Nutritional Index in Patients with Cancer Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Xu XT; Qian Y; Tian MX; Ding CC; Guo H; Tang J; Pi GL; Wu Y; Dai Z; Jin X
    Nutr Cancer; 2023; 75(6):1413-1426. PubMed ID: 37140894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
    Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S
    Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors.
    Chen N; Yu Y; Shen W; Xu X; Fan Y
    Clin Nutr; 2024 Jan; 43(1):142-153. PubMed ID: 38043419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors.
    Sun H; Chen L; Huang R; Pan H; Zuo Y; Zhao R; Xue Y; Song H
    Front Nutr; 2022; 9():1038118. PubMed ID: 36438745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis.
    Luan CW; Tsai YT; Yang HY; Chen KY; Chen PH; Chou HH
    Sci Rep; 2021 Aug; 11(1):17117. PubMed ID: 34429476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment "prognostic nutritional index" as an indicator of outcome in lung cancer patients receiving ICI-based treatment: Systematic review and meta-analysis.
    Shao Y; Cao W; Gao X; Tang M; Zhu D; Liu W
    Medicine (Baltimore); 2022 Oct; 101(43):e31113. PubMed ID: 36316884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors.
    Yan X; Wang J; Mao J; Wang Y; Wang X; Yang M; Qiao H
    Front Nutr; 2023; 10():1213255. PubMed ID: 37575320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors.
    Zhang L; Ma W; Qiu Z; Kuang T; Wang K; Hu B; Wang W
    Front Immunol; 2023; 14():1219929. PubMed ID: 37545502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of neutrophil to lymphocyte ratio in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
    Zhang S; Qiu C; Yu H; Xu Y; Xu X
    Front Oncol; 2023; 13():1070019. PubMed ID: 37143942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
    Xia H; Zhang W; Zheng Q; Zhang Y; Mu X; Wei C; Wang X; Liu Y
    Heliyon; 2023 Aug; 9(8):e17400. PubMed ID: 37520982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study.
    Wu M; Zhu Y; Chen X; Wang X; Lin X; Yan X; Mo P; Ye Y; Zeng Y; Yang Y; Fu Z
    J Gastrointest Oncol; 2023 Feb; 14(1):54-63. PubMed ID: 36915449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of nutritional and inflammatory markers in patients with hepatocellular carcinoma who receive immune checkpoint inhibitors.
    Liu C; Zhao H; Zhang R; Guo Z; Wang P; Qu Z
    Oncol Lett; 2023 Oct; 26(4):437. PubMed ID: 37664652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis.
    Wang Z; Wang Y; Zhang X; Zhang T
    Clin Chim Acta; 2018 Nov; 486():303-310. PubMed ID: 30138620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Pretreatment Prognostic Nutritional Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.
    Mao C; Xu W; Ma W; Wang C; Guo Z; Yan J
    Front Oncol; 2021; 11():719941. PubMed ID: 34676162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis.
    Takenaka Y; Oya R; Takemoto N; Inohara H
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1122-1135. PubMed ID: 34337889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
    Chen X; Meng F; Jiang R
    Front Oncol; 2021; 11():746976. PubMed ID: 34900692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.